Biosynex Nordic ApS: Financial statements 2020
CVR: 38417541
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Biosynex Nordic ApS (CVR 38417541) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 5,123,345 and a net result of DKK 3,975,373 compared with DKK 177,948 the year before. That is an increase of 2,121.3% compared with the year before. Equity in the 2020 report amounted to DKK 4,174,542. The solvency ratio was 37.9%.
- Gross Profit
- DKK 5,123,345
- Profit/Loss
- DKK 3,975,373
- Equity
- DKK 4,174,542
- Total Assets
- DKK 11,022,748
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 5.1M | 4M | 4.2M | 0 |
| 2019 | - | 231K | 178K | 199K | 0 |
| 2018 | - | -35K | -29K | 21K | 0 |
| 2017 | 356K | 840 | 664 | 51K | - |
Official annual report
How creditworthy is Biosynex Nordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Biosynex Nordic ApS has published its annual report for 2019. Gross profit came to DKK 230,642, and the net result was DKK 177,948.
About Biosynex Nordic ApS
Biosynex Nordic ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017. The company has been dissolved on 7 July 2025. The company was registered under the industry Billeddiagnostiske undersøgelser og medicinske laboratorieaktiviteter. The company was previously named Biosynex Nordic A/S and Medkoncept A/S. The company has 2 employees (2025). In 2023, the company reported a gross profit of DKK -1,062,001 and a net result of DKK -3,931,794 compared with DKK 41,802,660 the year before. Equity in the 2023 report amounted to DKK -3,814,178.